L
Lexeo Therapeutics, Inc. (LXEO)
NGM – Real Time Price. Currency in USD
4.75
+0.05 (1.06%)
At close: Jun 26, 2026, 4:00 PM EDT
4.75
-0.00 (-0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
4.75
+0.05 (1.06%)
At close: Jun 26, 2026, 4:00 PM EDT
4.75
-0.00 (-0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $71.8M significantly exceed its total debt $7.4M, ensuring strong financial flexibility
Total current assets $200.9M exceed Total current liabilities $14.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-1,313.7x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$21.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 14.16 | 6.05 | 10 | |
| Quick ratio | 14.16 | 5.63 | 10 | |
| Debt to Equity | 0.03 | 0.30 | 9.0 | |
| Debt to Assets | 0.03 | 1.04 | 9.0 | |
| Interest coverage | -1313.71 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 654K | N/A | N/A | N/A | N/A |
| Gross Profit | -491K | -2M | -2M | -2M | -2M |
| Operating Income | -61M | -69M | -106M | -109M | -98M |
| Net Income | -59M | -66M | -98M | -100M | -88M |
| EBITDA | -59M | -67M | -104M | -107M | -96M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 52.02 | 5.5 |
| Next quarter | N/A | 7.02 | 3.0 |
| Current year | N/A | 37.1 | 5.5 |
| Next year | N/A | -9.04 | 1.0 |
| Weighted average score | 3.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 3.46 | 7.41 | -5.47 | 5.0 |
| Y/Y | 999 | 38.16 | 74.75 | 2.47 | 8.3 |
| 3y average | 632.67 | -20.57 | 57.45 | -21.85 | 5.5 |
| 5y average | 411.42 | -192.24 | N/A | -281.31 | 3.3 |
| Weighted average score | 5.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |